---
title: "Chest CT–derived multi‑organ aging (MOSAIC‑Age) predicts chronic disease risk and mortality"
id: "medrxiv-12-multi-organ-aging-quantified-from-routine-chest-ct-predicts-chronic-disease"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-12-multi-organ-aging-quantified-from-routine-chest-ct-predicts-chronic-disease"
content_type: "clinical_feed_article"
specialty: "Radiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.26.26361434v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Chest CT–derived multi‑organ aging (MOSAIC‑Age) predicts chronic disease risk and mortality
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-12-multi-organ-aging-quantified-from-routine-chest-ct-predicts-chronic-disease
- **Specialty:** [Radiology](https://medichelpline.com/clinical-feed/radiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.26.26361434v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Researchers developed MOSAIC‑Age, a framework that quantifies **organ‑specific aging** from routine **chest CT** by constructing eight organ aging clocks visible on thoracic CT. - Models were developed and validated using 9,971 CT scans from the CT‑RATE and MIDRC datasets, then locked and applied to two independent prospective cohorts totaling 35,293 participants from the National Lung Screening Trial (NLST) and the Genetic Epidemiology of COPD (COPDGene) study. - The framework produces CT‑derived **biological age gaps (BAGs)**: the difference between an organ’s CT‑predicted age and chronological age; higher BAGs indicate organs that appear older than expected. - Higher BAGs were broadly associated with adverse lifestyle and socioeconomic factors, greater prevalent comorbidity burden, incident chronic diseases, and increased all‑cause and cause‑specific mortality risk. - Some disease outcomes were associated with aging across multiple thoracic organs; when all eight organ‑specific BAGs were analyzed together, many associations that persisted were organ specific. - A larger number of markedly older‑appearing organs and a faster pace of aging were each linked to higher mortality in the study cohorts. - Authors propose that routine chest CT captures both shared and organ‑specific patterns of biological aging and that CT‑derived organ aging may serve as a quantitative imaging biomarker for assessing multi‑organ health and long‑term disease risk. - Model weights and some imaging data availability are described: CT‑RATE via Hugging Face, MIDRC via MIDRC Data Commons, NLST via The Cancer Imaging Archive and NCI CDAS, COPDGene via dbGaP; pretrained organ‑clock model weights and paired CT/PET‑CT data are available from the corresponding author on request. - Ethical approval was provided by the Institutional Review Board of The University of Texas MD Anderson Cancer Center. Multiple authors disclosed industry relationships and funding sources; remaining authors reported no competing interests.
## Clinical Analysis & Structured Key Points
Multi-organ aging quantified from routine chest CT predicts chronic disease risk and mortality | medRxiv Skip to main content Multi-organ aging quantified from routine chest CT predicts chronic disease risk and mortality View ORCID Profile Junya Sato , Morteza Salehjahromi , Anas Zafar , Amgad Muneer , Xinyan Xu , Erjia Zhu , Natalie I. Vokes , Tina Cascone , Xiuning Le , Mehmet Altan , Eric E. Gardner , Ajay Sheshadri , Edwin J. Ostrin , Ameen A. Salahudeen , Tianhong Li , Miriam Merad , Aadel A. Chaudhuri , David E. Gerber , Fernando U. Kay , Myrna C.B. Godoy , Brett W. Carter , Girish S. Shroff , Lauren A. Byers , Caroline Chung , David Jaffray , David Rice , Zhongxing Liao , Joe Y. Chang , Ara A. Vaporciyan , Don L. Gibbons , Carol C. Wu , John V. Heymach , Jianjun Zhang , Jia Wu doi: https://doi.org/10.64898/2026.08.26.26361434 Junya Sato 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Junya Sato Morteza Salehjahromi 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anas Zafar 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amgad Muneer 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xinyan Xu 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Erjia Zhu 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Natalie I. Vokes 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tina Cascone 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xiuning Le 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mehmet Altan 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eric E. Gardner 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ajay Sheshadri 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Edwin J. Ostrin 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ameen A. Salahudeen 2 University of Illinois Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tianhong Li 3 UC Davis Comprehensive Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Miriam Merad 4 Icahn School of Medicine at Mount Sinai; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aadel A. Chaudhuri 5 Mayo Clinic; Find this author on Google Scholar Find this author on PubMed Search for this author on this site David E. Gerber 6 UT Southwestern Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Fernando U. Kay 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Myrna C.B. Godoy 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Brett W. Carter 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Girish S. Shroff 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Lauren A. Byers 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Caroline Chung 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site David Jaffray 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site David Rice 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Zhongxing Liao 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joe Y. Chang 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ara A. Vaporciyan 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Don L. Gibbons 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Carol C. Wu 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site John V. Heymach 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jianjun Zhang 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jia Wu 1 The University of Texas MD Anderson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: jwu11{at}mdanderson.org Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Biological aging occurs heterogeneously across individuals and organs. However, current measures of biological age incompletely capture organ-specific differences in health and disease risk. Because chest CT visualizes multiple thoracic organs, it offers an opportunity to quantify structural aging across organ systems. Here, we developed MOSAIC-Age, a framework characterizing eight organ-specific aging clocks on chest CT. The clocks were developed and validated using 9,971 CT scans from CT-RATE and MIDRC, and subsequently locked and applied to two independent prospective cohorts with 35,293 participants from the National Lung Screening Trial and Genetic Epidemiology of COPD study. CT-derived biological age gaps (BAGs) were examined in relation to lifestyle and socioeconomic factors, prevalent comorbidities, incident chronic diseases, and all-cause and cause-specific mortality. Higher BAGs, indicating organs that appeared older on CT than expected for their chronological age, were broadly associated with adverse health characteristics, chronic disease burden, and increased mortality risk. Multiple disease outcomes were associated with aging across several organs, whereas in multivariable analyses including all eight organ-specific BAGs, the remaining associations were more organ specific. A greater number of markedly older-appearing organs and a faster pace of aging were each associated with higher mortality. Together, these findings demonstrate that routine chest CT captures both shared and organ-specific patterns of biological aging and establish CT-derived organ aging as a quantitative imaging biomarker for assessing multi-organ health and long-term disease risk. Competing Interest Statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: N. I. V. receives consulting fees from Regeneron, Amgen, Xencor, AstraZeneca, Tempus, Pfizer, Summit, OncoHost, Guardant, ImmunityBio, and research funding from EMD Serono, IDEAYA, Amgen, Summit, Regeneron, Sanofi, BMS, and OncoHost, outside the submitted work. M.C.B.G. has received research funding from Siemens Healthcare. T. C. reports speaker fees/honoraria (including travel/meeting expenses) from ASCO Post, AstraZeneca, Bio Ascend, Bristol Myers Squibb, Clinical Care Options, IDEOlogy Health, Medical Educator Consortium, Medscape, OncLive, PeerView, Physicians' Education Resource, Targeted Oncology; advisory role/consulting fees (including travel/meeting expenses) from AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Genentech, Johnson & Johnson, Merck, Nuvalent, oNKo-innate, Pfizer, and RAPT Therapeutics; and institutional research funding from AstraZeneca, Bristol Myers Squibb and Merck. X. L. reports receiving consultant and advisory fees from Eli Lilly, AstraZeneca, EMD Serono, Daiichi Sankyo, Spectrum Therapeutics, Boehringer Ingelheim, Hengrui Therapeutics, Novartis, and research funding from Eli Lilly, Boehringer Ingelheim, all outside of the submitted work. M. A. reports research funding from Genentech, Nektar Therapeutics, Merck, GlaxoSmithKline, Novartis, Jounce Therapeutics, Bristol Myers Squibb, Eli Lilly, Adaptimmune, Shattuck Labs, Gilead, Verismo Therapeutics, and Lyell; advisory board roles for GlaxoSmithKline, Shattuck Labs, Bristol Myers Squibb, AstraZeneca, Insightec, Regeneron, Genprex, and Lyell; speaker fees from AstraZeneca, Nektar Therapeutics, SITC, and Regeneron; and participation on a safety review committee for Nanobiotix-MDA Alliance, Henlius, all outside of the submitted work. A.A.S. reports serving on the advisory board of DELFI Diagnostics and as an advisor to Droplet Biosciences, all outside of the submitted work. D.E.G. reports research funding from AstraZeneca, Karyopharm, and Novocure; stock ownership in Gilead and Medtronic; stock options in Early Marker, Inc. and OncoSeer Diagnostics, Inc.; consulting and advisory roles for AbbVie, AstraZeneca, Bayer, Catalyst Pharmaceuticals, EMD Serono, and GSK; service on data and safety monitoring boards for Daiichi Sankyo, Summit Therapeutics, and Taiho Oncology; royalties from Oxford University Press; and roles as co-founder and Chief Medical Officer of OncoSeer Diagnostics, Inc., all outside of the submitted work. J. Y. C. has received travel sponsorship from Accuray and Varian Medical Systems, and grants from Varian Medical Systems, outside the submitted work. D. L. G. reports honoraria for scientific advisory boards from AstraZeneca, Sanofi, Alethia Biotherapeutics, Menarini, Eli Lilly, 4D Pharma and Onconova, and research support from Janssen, Takeda, Astellas, Ribon Therapeutics, NGM Biopharmaceuticals, Boehringer Ingelheim, Mirati Therapeutics and AstraZeneca, all outside of the submitted work. C. C. W. reports research support from Medical Imaging and Data Resource Center from NIBIB/University of Chicago and royalties from Elsevier, outside of the submitted work. J. V. H. reports receiving advisory/consulting fees from AstraZeneca, Boehringer Ingeheim, Catalyst, Genentech, GlaxoSmithKline, Guardant Health, Foundation Medicine, Hengrui Therapeutics, Eli Lilly, Novartis, Spectrum, Sanofi, Takeda Pharmaceuticals, Mirati Therapeutics, Bristiol Myers Squibb, BrightPath Biotherapeutics, Janssen Global Services, Nexus Health Systems, EMD Serono, Pneuma Respiratory, Kairos Venture Investments, Leads Biolabs, RefleXion, and research funding from GlaxoSmithKline, AstraZeneca, Spectrum, all outside of the submitted work. J. Z. reports grants from Merck, Novartis, Johnson and Johnson; and personal fees from BMS, AZ, Novartis, Johnson and Johnson, GenePlus, Hengrui, Innovent, outside the submitted work. J. W. reports research funding from Siemens Healthcare. The remaining authors declare that they have no competing interests. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Institutional Review Board of The University of Texas MD Anderson Cancer Center gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability CT-RATE imaging data are available through the Hugging Face repository under the repository's access conditions for academic, research, and educational use (https://huggingface.co/datasets/ibrahimhamamci/CT-RATE). MIDRC imaging data are available through the MIDRC Data Commons to registered users under the applicable MIDRC data use agreement (https://data.midrc.org/). The NLST imaging data are available through The Cancer Imaging Archive (https://www.cancerimagingarchive.net/collection/nlst/), and NLST clinical data are available through the NCI Cancer Data Access System (https://cdas.cancer.gov/nlst/). The COPDGene phenotype and imaging data used in this study are available through controlled access via dbGaP under study accession numbers phs000179.v7.p2 and phs004023.v1.p2, respectively. The paired CT/PET-CT data are not publicly available owing to patient privacy considerations but are available for research purposes from the corresponding author upon reasonable request. The pretrained organ-clock model weights are also available from the corresponding author upon reasonable request. Funder Information Declared National Institutes of Health , R01CA262425 , R01CA276178 Cancer Prevention and Research Institute of Texas , RP240117 Victory Houston Permanent Health Funds QIAC Partnership in Research Grant Rexanna's Foundation for Fighting Lung Cancer Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Posted August 31, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Multi-organ aging quantified from routine chest CT predicts chronic disease risk and mortality Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Multi-organ aging quantified from routine chest CT predicts chronic disease risk and mortality Junya Sato , Morteza Salehjahromi , Anas Zafar , Amgad Muneer , Xinyan Xu , Erjia Zhu , Natalie I. Vokes , Tina Cascone , Xiuning Le , Mehmet Altan , Eric E. Gardner , Ajay Sheshadri , Edwin J. Ostrin , Ameen A. Salahudeen , Tianhong Li , Miriam Merad , Aadel A. Chaudhuri , David E. Gerber , Fernando U. Kay , Myrna C.B. Godoy , Brett W. Carter , Girish S. Shroff , Lauren A. Byers , Caroline Chung , David Jaffray , David Rice , Zhongxing Liao , Joe Y. Chang , Ara A. Vaporciyan , Don L. Gibbons , Carol C. Wu , John V. Heymach , Jianjun Zhang , Jia Wu medRxiv 2026.08.26.26361434; doi: https://doi.org/10.64898/2026.08.26.26361434 Share This Article: Copy Citation Tools Multi-organ aging quantified from routine chest CT predicts chronic disease risk and mortality Junya Sato , Morteza Salehjahromi , Anas Zafar , Amgad Muneer , Xinyan Xu , Erjia Zhu , Natalie I. Vokes , Tina Cascone , Xiuning Le , Mehmet Altan , Eric E. Gardner , Ajay Sheshadri , Edwin J. Ostrin , Ameen A. Salahudeen , Tianhong Li , Miriam Merad , Aadel A. Chaudhuri , David E. Gerber , Fernando U. Kay , Myrna C.B. Godoy , Brett W. Carter , Girish S. Shroff , Lauren A. Byers , Caroline Chung , David Jaffray , David Rice , Zhongxing Liao , Joe Y. Chang , Ara A. Vaporciyan , Don L. Gibbons , Carol C. Wu , John V. Heymach , Jianjun Zhang , Jia Wu medRxiv 2026.08.26.26361434; doi: https://doi.org/10.64898/2026.08.26.26361434 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (613) Allergy and Immunology (895) Anesthesia (325) Cardiovascular Medicine (4765) Dentistry and Oral Medicine (474) Dermatology (406) Emergency Medicine (641) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1612) Epidemiology (15825) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6979) Geriatric Medicine (727) Health Economics (1056) Health Informatics (4968) Health Policy (1424) Health Systems and Quality Improvement (1733) Hematology (579) HIV/AIDS (1333) Infectious Diseases (except HIV/AIDS) (16239) Intensive Care and Critical Care Medicine (1160) Medical Education (663) Medical Ethics (150) Nephrology (720) Neurology (7184) Nursing (363) Nutrition (1072) Obstetrics and Gynecology (1230) Occupational and Environmental Health (999) Oncology (3567) Ophthalmology (1035) Orthopedics (393) Otolaryngology (446) Pain Medicine (464) Palliative Medicine (139) Pathology (702) Pediatrics (1772) Pharmacology and Therapeutics (732) Primary Care Research (758) Psychiatry and Clinical Psychology (5827) Public and Global Health (9678) Radiology and Imaging (2384) Rehabilitation Medicine and Physical Therapy (1431) Respiratory Medicine (1239) Rheumatology (633) Sexual and Reproductive Health (765) Sports Medicine (574) Surgery (765) Toxicology (107) Transplantation (302) Urology (285)
## Related Clinical Research

- [Pemafibrate as a senotherapeutic for COPD via TFEB-driven autophagy and mitophagy regulation](https://medichelpline.com/clinical-feed/medrxiv-4-senotherapeutic-role-of-pemafibrate-through-autophagy-mitophagy-regulation-in.md)
- [Sirtuins in Lung Disease: Mechanisms, Clinical Implications, and Translational Advances](https://medichelpline.com/clinical-feed/pubmed-42663289.md) (DOI: 10.3892/ijmm.2026.5967)
- [Albumin-Corrected Anion Gap Predicts In-Hospital Mortality in Traumatic Lung Injury: Multicenter R](https://medichelpline.com/clinical-feed/pubmed-42626900.md) (DOI: 10.1177/10815589261483651)
- [Translational modelling questions receptor‑occupancy‑based dosing for pembrolizumab (PD‑1 inhibito](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-translational-modelling-challenges-receptor-occupancy-based-dosing-of-pd-1.md)
- [PD-L1 expression and survival in unresectable or recurrent gastric cancer treated with first-line](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-pd-l1-expression-and-survival-in-unresectable-recurrent-gastric-cancer-treated.md)

## Navigation
- [← Back to Radiology Feed](https://medichelpline.com/clinical-feed/radiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.